Cirius Therapeutics Patents – Insights & Stats (Updated 2023)

Cirius Therapeutics has a total of 31 patents globally, out of which 24 have been granted. Of these 31 patents, more than 83% patents are active. New Zealand is where Cirius Therapeutics has filed the maximum number of patents, followed by Hungary and Austria. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Cirius Therapeutics.

Cirius Therapeutics was founded in the year 2015. The Company operates as a pharmaceutical company. The Company develops insulin sensitizer for the treatment of non-alcoholic steatohepatitis.

Do read about some of the most popular patents of Cirius Therapeutics which have been covered by us in this article and also you can find Cirius Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Cirius Therapeutics patent portfolio.

How many patents does Cirius Therapeutics have?

Cirius Therapeutics has a total of 31 patents globally. These patents belong to 5 unique patent families. Out of 31 patents, 26 patents are active.

How Many Patents did Cirius Therapeutics File Every Year?

Cirius Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantCirius Therapeutics Applications FiledCirius Therapeutics Patents Granted
20179
20166
20152
20141
20134
20122
201118
201011
20082

How many Cirius Therapeutics patents are Alive/Dead?

Cirius Therapeutics Patent Portfolio

How Many Patents did Cirius Therapeutics File in Different Countries?

Cirius Therapeutics Worldwide Patent Filing

Countries in which Cirius Therapeutics Filed Patents

CountryPatents
New Zealand6
Hungary3
Austria3
Germany3
Norway3
Denmark3
Poland3
Europe3
Spain3
Korea (South)1

Where are Research Centres of Cirius Therapeutics Patents Located?

R&D Centers of Cirius Therapeutics

 List of Cirius Therapeutics Patents

Cirius Therapeutics PatentsTitle
EP2512470B1Ppar-Sparing Thiazolidinediones And Combinations For The Treatment Of Neurodegenerative Diseases
EP2603498B1Novel Synthesis For Thiazolidinedione Compounds
EP2560956B1Novel Synthesis For Thiazolidinedione Compounds
NZ606574BNovel Synthesis For Thiazolidinedione Compounds
NZ602883BNovel Synthesis For Thiazolidinedione Compounds
NZ600390BPpar-Sparing Thiazolidinedione Salts For The Treatment Of Metabolic Diseases
NZ597381BThiazolidinedione Analogues For The Treatment Of Hypertension
NZ583889BThiazolidinedione Analogues For The Treatment Of Hypertension
PL2603498T3Novel Synthesis For Thiazolidinedione Compounds
PL2512470T3Ppar-Sparing Thiazolidinediones And Combinations For The Treatment Of Neurodegenerative Diseases
ES2617704T3Ppar-Sparing Thiazolidinediones And Combinations For The Treatment Of Neurodegenerative Diseases
ES2610623T3Novel Synthesis For Thiazolidinedione Compounds
ES2609837T3Novel Synthesis For Thiazolidinedione Compounds
PL2560956T3Novel Synthesis For Thiazolidinedione Compounds
DK2560956T3Hitherto Unknown Synthesis Of Thiazolidine Dione Compounds
DK2603498T3Hitherto Unknown Synthesis Of Thiazolidine Dione Compounds
DE602011032206T2Novel Synthesis For Thiazolidedione Compounds
DE602011031654T2Novel Synthesis For Thiazolidedione Compounds
NO2603498B1Novel Synthesis For Thiazolidinedione Compounds
NO2560956B1Novel Synthesis For Thiazolidinedione Compounds
NO2512470B1Ppar-Sparing Thiazolidinediones And Combinations For The Treatment Of Neurodegenerative Diseases
HUE033199T2Ppar-Sparing Thiazolidinediones And Combinations For The Treatment Of Neurodegenerative Diseases
HUE031424T2Novel Synthesis For Thiazolidinedione Compounds
HUE030263T2Novel Synthesis For Thiazolidinedione Compounds
AT839905TNovel Synthesis Of Thiazolidinedione Compounds
AT843783TNovel Synthesis Of Thiazolidinedione Compounds
NZ600421BPpar-Sparing Thiazolidinediones And Combinations For The Treatment Of Neurodegenerative Diseases
DK2512470T3Ppar-Sparing Thiazolide Diones And Combinations For The Treatment Of Neurodegenerated Diseases
DE602010038493T2Ppar-Immediate Thiazolidinediones And Combinations For The Treatment Of Neurodegenerative Diseases
AT849152TPpar-Bypassing Thiazolidinediones And Combinations For The Treatment Of Neurodegenerative Diseases
KR1020120103711APpar-Sparing Thiazolidinediones And Combinations For The Treatment Of Neurodegenerative Diseases

What are Cirius Therapeutics key innovation segments?

What Technologies are Covered by Cirius Therapeutics?

The chart below distributes patents filed by Cirius Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Cirius Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Cirius Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Cirius Therapeutics?

Related Articles

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.